We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Denied Summary Judgment In Antitrust Case

Law360 (March 12, 2009, 12:00 AM EDT) -- A federal judge has refused Mylan Laboratories Inc.'s bid to dismiss claims related to the anti-anxiety drug lorazepam in a lawsuit alleging the drugmaker conspired with competitors to inflate drug prices.

Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts on Wednesday denied Mylan's summary judgment motion in the suit with Massachusetts, rejecting the drugmaker's argument that a judgment in an earlier case barred the claims.

Mylan reached an agreement in 2002 with the U.S. Federal Trade Commission and several states...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.